Rifaximin

Rifaximin is indicated for the treatment of patients with traveler's diarrhea caused by noninvasive strains of Escherichia coli at lower dose. Rifaximin is also indicated for reduction in risk of overt hepatic encephalopathy (HE) at higher dose.

There are no products to list in this category.

Continue